Compania de Cannabis Medicinal Greenscience S.A. Company Profile - Ecuador | Financials & Key Executives

Compania de Cannabis Medicinal Greenscience S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing

Secondary Activities: All Other Crop Farming | Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores

Full name: Compania de Cannabis Medicinal Greenscience S.A.

Profile Updated: April 10, 2023

Compania de Cannabis Medicinal Greenscience S.A. is based in Ecuador. The head office is in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on June 25, 2020. The total number of employees is currently 3 (2021). Its’ total assets recorded a growth of 0.36%.

Headquarters
Geovanni Calles 12-27
Quito; Pichincha;

Contact Details: Purchase the Compania de Cannabis Medicinal Greenscience S.A. report to view the information.

Basic Information

Total Employees:

Purchase the Compania de Cannabis Medicinal Greenscience S.A. report to view the information.

Outstanding Shares:

Purchase the Compania de Cannabis Medicinal Greenscience S.A. report to view the information.

Registered Capital:

Purchase the Compania de Cannabis Medicinal Greenscience S.A. report to view the information.

Incorporation Date:

June 25, 2020

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

80%

Purchase this report to view the information.

20%

Company Performance

Financial values in the chart are available after Compania de Cannabis Medicinal Greenscience S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net Profit (Loss) for the Period

N/A

Total assets

0.36%▲

Total equity

9.02%▲

Return on Equity (ROE)

N/A

Similar companies

Related EMIS Industry Reports